CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

BioPharma Dive
Original article

North Immunology joins biotech reverse merger boom with Aethlon deal

Positive
AI Analysis

Summary

North Immunology is merging with Aethlon in a reverse merger deal, bringing $180 million in funding and a dual-acting antibody for eczema to capitalize on increased biotech reverse merger activity.

Importance:7/10
Sentiment:
0.60
reverse mergerantibodyeczemaNorth ImmunologyAethlonM&A

Read the original article

Published by BioPharma Dive on September 17, 2026 3:09 PM

Read Original